SNY, BMY, REGN and others ramp up 2025 dealmaking as pharma/biotech giants chase innovation across key growth areas.

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...

The UK Financial Conduct Authority teams up with Nvidia to launch a powerful AI sandbox, giving financial firms access to ...

Oil prices dipped slightly on weak Chinese economic data, but broader market sentiment remains buoyant ahead of crucial ...